International Society of Hypertension

New Investigators Network

New Investigator Network

  • Register to attend the 8th ISH African Hypertension Teaching Seminar: DEADLINE EXTENDED TO 1 FEBRUARY

    Submit your application today to join the ISH at our 8th Africa Teaching Seminar. This event is designed for medical professionals up to the age of 50 years and residing in Africa, who are involved in the management and/or research in hypertension or hypertension-related fields.

    Read More 26/01/2016

  • Nguyen Van Thao interview - January new investigator of the month

    Read on to find out how Nguyen Van Thao became involved in research relating to Hypertension and Cardiovascular Disease and what advice he has for talented emerging scientists.

    Read More 20/01/2016

  • India: Certificate Course in Management of Hypertension (CCMH)

    The Certificate Course in Management of Hypertension (CCMH) is a joint certification program designed, implemented and delivered by Public Health Foundation of India in collaboration with academic partners Center for Chronic Disease Control (CCDC) and knowledge partners International Society of Hypertension (ISH) and British Hypertension Society (BHS). The educational grant for the same has been provided by Sun Pharma.

    Read More 19/01/2016

  • EXTENDED ABSTRACT DEADLINE TO 25 JANUARY: XX111 Argentine Hypertension Meeting

    The Argentine Society of Hypertension (SAHA) is pleased to invite new investigators (in particular those based in Latin America) to join them at the XX111 Argentine Hypertension Meeting. This event will be held in Buenos Aires from 14-16 April 2016 and the ISH New Investigator Committee is delighted to be collaborating with SAHA onthis initiative.

    Read More 19/01/2016

  • Renew your ISH 2016 membership

    Receive your annual subscription to the Journal of Hypertension, substantial savings on registration fees for the ISH Biennial Scientific Meetings and much more.

    Read More 10/12/2015

  • An interview with Amit Tirosh - ISH December new investigator of the month

    Amit is a Senior Endocrinologist at Rabin Medical Center, Israel. Visiting attending endocrinologist, National Institutes of Health. He is interested in the diagnosis of hypercortisolism, and in the prevention of its deleterious effects, including hypertension, hyperglycemia and hypercoagulability.

    Read More 02/12/2015

  • Sex, drugs and trials galore

    We are delighted to present you with the December 2015 issue of ISH Hypertension News.
    This includes coverage of the results of four trials, all of which have important implications for clinical practice in relation to improving CVD prevention. Three of these trials - SPRINT and two PATHWAYS trials - have clinical implications for hypertension management (how low to go and how to do it) and one EMPA-REG provides unique data regarding optimal glucose lowering with a new class of agents for the prevention of CVD in patients with type 2 diabetes!

    Read More 02/12/2015

  • Report of the XXIII Congress of the Brazilian Society of Hypertension

    ISH representatives (the President - Rhian Touyz and Immediate Past President - Ernesto Schiffrin) were delighted to attend the Brazilian Society of Hypertension Congress, which was held at the Windsor Barra Hotel, Rio de Janeiro, Brazil from 13-15 August 2015. An event report follows kindly supplied by Mario Fritsch T. Neves.

    Read More 25/11/2015

  • WHO Meeting on Cardiovascular Prevention on a Global Scale

    A global World Health Organization (WHO) meeting was held in Geneva from 28-30 October to address issues related to cardiovascular prevention. This was the last of four meetings on strategies to combat non-communicable diseases. I was pleased to represent ISH on this occasion and took the opportunity to argue for aspects on hypertension control as part of a more general strategy to control cardiovascular risk factors.

    Read More 13/11/2015

  • Major Clinical Trial on Hypertension indicates the importance of intensive treatment

    It has been a while since there has been a landmark clinical trial on hypertension and I would like to bring the following important paper and accompanying Commentaries to your attention:

    Read More 11/11/2015

Join ISH in 3 simple steps...Apply Now

Latest tweets from ISH

The ISH is positively committed to opposing discrimination against people on the grounds of gender, race, colour, nationality, religion, marital status, sexual orientation, class, age, disability, having dependants, HIV status or perceived lifestyle.